Serum selenium level and other risk factors for breast cancer among patients in a Malaysian hospital

Environmental Health and Preventive Medicine

Volumn 12, Issue 3, 2007, Pages 105-110

  Rejali, Lokman ^a   Jaafar, Mohd Hasni ^a   Ismail, Noor Hassim ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Breast cancer; Glutathione peroxides enzyme; Nulliparity; Oral contraceptives; Selenium

Indexed keywords

ORAL CONTRACEPTIVE AGENT; SELENIUM;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MCNEMAR TEST; MENOPAUSE; MULTIVARIATE ANALYSIS; NULLIPARA; RISK FACTOR;

EID: 34250186110     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1265/ehpm.12.105     Document Type: Article

References (32)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: The global picture. Eur J Cancer. 2001;37:4-66.
2. McPherson K, Steel CM, Dixon JM. Breast cancer epidemiology, risk factors and genetics: clinical review. Br Med J. 2000;321:624-628.
3. Ministry of Health. National Health and Morbidity Survey Report. Ministry of Health: Kuala Lumpur, Malaysia; 1997.
4. Clark LC, Cantor KP, Allaway W. Selenium in forage crops and cancer mortality in US counties. Arch Env Health. 1991;46:37-42.
5. Harr JR. Effect of dietary selenium on N-2-fluorenylacetamide (FAA): Induced cancer in vitamin E-supplemented selenium depleted rat. Clin Toxicol. 1972;5:187-194.
6. Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J. 1969;104:82-84.
7. Shamberger RJ, Willis CE. Selenium distribution and human cancer mortality. Crit Rev Clin Lab Sci. 1971;2:211-221.
8. Xiu YQ, An YZ, Guang LW, Wen ZP. The association between breast cancer and other factors. Asia Pacific J Pub Health. 1994;7:98-104.
9. Ge K, Yang G. The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr. 1993;57:259-263.
10. Hunter DJ, Morris JS, Stampher MJ, Colditz GA, Speizer FE, Willett WC. A prospective study of selenium status and breast cancer risk. J Am Med Assoc. 1990;264:1128-1131.
11. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 1995;87:1681-1685.
12. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. J Am Med Assoc. 1993;270:1563-1568.
13. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol. 1990;131;961-972.
14. Collaborative Group on Hormonal Factors in Breast Cancer. Collaborative group on hormonal factors in breast cancer: Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713-1727.
15. Steinberg KK, Thacker SB, Smith SJ. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. J Am Med Assoc. 1991;265:1985-1990.
16. Tee ES. Changing dietary intake and food consumption in Malaysia: National implications. Institute for Medical Research: Kuala Lumpur, Malaysia; 1995.
17. Thomas CT. Methods for biological monitoring: a manual for assessing human exposure to hazardous substances. In: Kneip TJ, Crable JV editors. Washington: American Public Health Association; 1988. p. 237-240.
18. Amstrong K, Eisen A, Weber B. Primary care: Assessing the risk of breast cancer. N Engl J Med. 2000;342:564-571.
19. Cui Y, Miller AB, Rohan TE. Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat. 2006;100:293-298.
20. Combs GF, Clark LC. Can dietary selenium modify cancer risk? Nutr Rev. 1985;43:325-331.
21. Vernie LN. Selenium in carcinogenesis. Biochim Biophys Acta. 1984;738:203-217.
22. Schrauzer GN, Molenaar T, Mead S, Kuehn K, Yamamoto H, Araki E. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn J Cancer Res. 1985;76:374-377.
23. Dupont WD, Page DL. Breast cancer risk associated with proliferative disease, age at first birth and a family history of breast cancer. Am J Epidemiol. 1987;125:769-779.
24. Helmrich SP, Shapiro S, Rosenberg L, Kaufman DW, Slone D, Bain C, et al. Risk factors for breast cancer. Am J Epidemiol. 1983;117:35-45.
25. Lipnick R, Speizer FE, Bain C, Willett W, Rosner B, Stampfer MJ, et al. A case-control study of risk indicators among women with premenopausal and early postmenopausal breast cancer. Cancer. 1984;53:1020-1024.
26. Soini I. Risk factors of breast cancer in Finland. Int J Epidemiol. 1977;6:365-373.
27. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: Findings from the European Prospective Investigation into Cancer And Nutrition. Int J Cancer. 2004;111:762-771.
28. Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K, Texter L. Body mass index and breast cancer risk in African American women. Ann Epidemiol. 2005;15:123-128.
29. Tao MH, Shu XO, Ruan ZX, Gao YT, Zheng W. Association of overweight with breast cancer survival. Am J Epidemiol. 2006;163:101-107.
30. Hunter DJ, Spiegelman D, Adami H, Beeson L, van den Brandt P, Folsom AR, et al. Cohort studies of fat intake and the risk of breast cancer: A pooled analysis. N Engl J Med. 1995;334:356-361.
31. Collaborative group on hormonal factors in breast cancer. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713-1727.
32. World Health Organization. International Program on Chemical Safety. World Health Organization: Geneva, Switzerland; 1987.